Congress Materials

Medical Information
Afrique
 

This medical information website is intended only for healthcare professionals in Africa. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a healthcare professional registered to practice in AfricaYes, I am a healthcare professional
SelectI am a healthcare professional registered to practice in AfricaYes, I am a healthcare professional
I am not a Healthcare ProfessionalNo, go back to the patient portal
SelectI am not a Healthcare ProfessionalNo, go back to the patient portal
Where do you work / live?
SubmitSubmit
I am a Healthcare Professional in another country.

Congress Materials

The information on this page pertains to selected congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.

Poster
Teixeira R, Sofia da Silva Maia A, Sundaram V, Wasserman M, McDade C, Wilson M, Perdizet J April 26, 2022 ECCMID 2022 Pneumococcal Disease

Comparing the Public Health Impact of a 15- or 20-valent Pneumococcal Conjugate Vaccine Pediatric National Immunization Program in Portugal

View Presentation
Poster
Sahrmann JA, Olsen MA, Yu H, Dubberke ER April 26, 2022 ECCMID 2022 Clostridium Difficile

Costs Attributable to Clostridioides difficile Infection (CDI) based on the setting of onset and need for hospitalisation

View Presentation
Poster
Le Bel J, Pinot J, Alfaiate T, Ecollan M, Cussac F, Pecqueur R, Revel MP, Vartanian C, Varon E, Theilacker C, Duval X, Partouche H, Laouénan C, Gilberg S April 26, 2022 ECCMID 2022 Pneumococcal Disease

Description and characterization of pneumococcal community acquired pneumonia among radiologically confirmed CAP in outpatients - Results from a multicenter observational study

View Presentation
Oral Presentation
Effelsberg N, Buchholz M, Kampmeier S, Schwierzeck V, Angulo FJ, Brestrich G, Martin C, Moïsi J, von Eiff C, von Müller L, Mellmann A April 26, 2022 ECCMID 2022 Clostridium Difficile

Frequency of stool diagnostics and potential underdiagnosis of Clostridioides difficile in hospitalised adults with diarrhoea in the Muenster/Coesfeld area, Germany

View Presentation
Poster
Cannon K, Cardona J, Belanger T, Lee D, Peng Y, Moyer L, Ginis J, Thompson A, Gruber WC, Jansen K, Scott DA, Yacisin K, Watson W April 26, 2022 ECCMID 2022 Pneumococcal Disease

Immunogenicity and safety of a 20-valent pneumoocccal conjugate vaccine (PCV20) administered concomitantly with a quadrivalent inactivated influenza vaccine in adults ≥ 65 years of age

View Presentation
Poster
Hyams C, Begier E, Southern J, King J, Morley A, Gonzalez MG, Szasz-Benczur Z, Kinney J, Campling J, Gray S, Oliver J, Hubler R, Valluri S, Vyse A, Ellsbury G, Gessner B, Finn A April 26, 2022 ECCMID 2022 Pneumococcal Disease

Incidence of Acute Lower Respiratory Tract Disease Hospitalisations among Adults in Bristol, United Kingdom 2020–21

View Presentation
Oral Presentation
Tateda K, Ishida J, Ito S, Gonzalez E, Yoshizumi S, Zhang P, Pride M, Gray S, Ferreira CM, Minarovic N, Angulo FJ, Moïsi JC, Jodar L April 26, 2022 ECCMID 2022 Clostridium Difficile

Population-based incidence of hospitalized Clostridioides difficile infection among older adults in Ota-ku, Japan: a prospective surveillance study

View Presentation
Oral Presentation
Pugh SJ, Moïsi, JC, Kundi M, Santonja I, Erber W, Angulo FJ, Jodar L April 26, 2022 ECCMID 2022 Tick-borne encephalitis

Real-World Effectiveness of Tick-borne Encephalitis (TBE) Vaccination: Available Prevention against TBE for Travelers to Endemic Areas

View Presentation
Poster
Fitz-Patrick D, Jennings T, Young M, Yacisin K, McElwee K, Belanger T, Belanger K, Peng Y, Lee DY, Gruber W, Scott D, Watson W April 26, 2022 ECCMID 2022 Pneumococcal Disease

Safety, Tolerability, and Immunogenicity of a Third Dose of BNT162b2 COVID-19 Vaccine Coadministered with 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 65 Years of Age and Above

View Presentation